A Pioneer in Minimally Invasive Prostate Cancer Treatment
Watch the video to hear our story
Preserving Quality of Life with Minimally Invasive Treatment Options
1 in 8 men will receive a prostate cancer diagnosis this year. Thousands will be told they have limited options, and that is not true.
HALO Diagnostics has been a pioneer in advancing minimally invasive prostate cancer treatment with reduced side effects. HALO provides a treatment pathway personalized for each individual prostate cancer or BPH diagnosis. Treatment options include:
mpMRI prostate screenings to identify areas of suspicious tissue before an invasive biopsy.
The HALO Diagnostics ensemble approach of mpMRI + PSAD + ExoDx misses 0% of clinically significant prostate cancer 13.5% of unnecessary biopsies are completely avoided.
HALO offers two focal therapeutic treatment options:
Laser Focal Therapy (LFT)
MRI-guided Laser Focal Therapy showed a better safety profile than standard treatments for patients with localized prostate cancer. (Source: Urology Times 2020)
Call 760-718-6353 to schedule your complimentary consultation with a HALO Diagnostics expert today or complete the form below.